Hledání článků
Filtry
Baigent C, Landray MJ, Reith C, et al., on behalf of the SHARP investigators. The effect of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo‑controlled trial. Lancet 2011, 377:2181–2192.
SHARP Collaborative Group: Study of Heart and Renal Protection (SHARP): randomized trial to assess the effects of lowering low‑density lipoprotein cholesterol among 9 438 patients with chronic kidney disease. Am Heart J 2010;160:785–794.
Gansevoort RT, Matsushita K.,van der Velde M, Astor BC, Woodward M, Levey AS, de Jong PE, Coresh J and Chronic Kidney Disease Prognosis Consortium. Lower estimated GFR and higher albuminuria are associated with adverse kidney outcomes. A collaborative meta‑analysis of general and high‑risk population cohorts. Kidney Int 2011;80:93–104.
Manno C, Bonifati C, Torres DD, Campobasso N, Schena FP. Desmopressin acetate in percutaneous ultrasound – guided kidney biopsy: A randomized controlled trial. Am J Kindey Dis 2011;57:850–855.
Herrmann SMS, Gertz MA, Stegall MD, et al. Long‑term outcomes of patients with light chain amyloidosis (AL) after renal transplantation with or without stem cell transplantation. Nephrol Dial Transplant 2011;26:2032–2036.
Nogueira EL, Costa AC, Santana A, Querna JO, Silva S, Mil‑Homens C, Costa AG. Teriparatide efficacy in the treatment of severe hypocalcemia after kidney transplantation in parathyreoidectomized patients: a series of five case reports. Transplantation 2011;92:316–320.
Hurst FP, Belur P, Nee R, Agodoa LY, Patel P, Abbott KC, Jindal RM. Poor outcomes associated with neutropenia after kidney transplantation: analysis of United States renal data system. Transplantation. 2011;92:36–40.
Gharavi AG, Kiryluk K, Choi M, et al. Genome‑wide association study identifies susceptibility loci for IgA nephropathy. Nature Genet 2011;43:321–327.
Hofstra JM, Willems JL, Wetzels JFM. Estimated glomerular filtration rate in the nephrotic syndrome. Nephrol Dial Transpl 2011;26:550–556.
Rognant N, Bacchetta J, Dubourg L, et al. What is the best alternative to inulin clearance to estimate GFR in patients with decompensated alcoholic cirrhosis? Nephrol Dial Transpl 2010;25:3569–3575.
Eyler RF, Mueller BA. Antibiotic dosing in critically ill patients with acute kidney injury. Nat Rev Nephrol 2011;7:226–235.
Szummer K, Lundman P, Jacobson SH, Schön S, Lindbäck J, Stenestrand U, Wallentin L, Jernberg T, for SWEDEHEART. Association between statin treatment and outcome in relation to renal function in survivors of myocardial infarction. Kidney Int 2011;79:997–1004.
Farese S, Stauffer E, Kalicki R, et al. Sodium thiosulfate pharmacokinetics in hemodialysis patients and healthy volunteers. Clin J Am Soc Nephrol 2011; 6:1447–1455.
Geetha D, Eirin A, True K, et al. Renal transplantation in antineutrophil cytoplasmic antibody‑associated vasculitis: A multicenter experience. Transplantation 2011;91:1370–1375.
La Manna G, Pizza F, Persici E, Baraldi O, Comai G, Cappuccilli ML, Centofanti F, Carretta E, Plazzi G, Colí L, Montagna P, Stefoni S. Restless legs syndrome enhances cardiovascular risk and mortality in patients with end‑stage kidney disease undergoing long‑term haemodialysis treatment. Nephrol Dial Transplant 2011;26:1976–1983.